Company Overview of Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc., a biotechnology company, develops vaccines for the prevention of common seasonal influenza and emergent pandemic flu. It focuses on developing live attenuated influenza vaccines by altering the gene for nonstructural protein 1 (NS1), a key virulence factor of influenza, and other negative-strand RNA viruses. The company was founded in 2006 and is based in New York, New York.
Bellevue Hospital Center
462 First Avenue
New York, NY 10016-9196
Founded in 2006
Key Executives for Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Key Developments
Similar Private Companies By Industry
|Del Pharmaceuticals, Inc.||United States|
|Genyous Life Sciences||United States|
|Nanopore Diagnostics, LLC||United States|
|HMR Pharma Inc.||United States|
|Alliqua BioMedical, Inc.||United States|
Recent Private Companies Transactions
October 10, 2013
|Baxter Healthcare S.A., Clinical-Stage Influenza Vaccine Assets|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Hyattsville, MD | University of Maryland University CollegePosted: Mar 04
- San Francisco, CA | Life TechnologiesPosted: Mar 13
- New York | Leading Financial Institution of CanadaPosted: Mar 05
- San Francisco, CA | Marina Sirras & AssociatesPosted: Mar 13
Sponsored Financial Commentaries
To contact Vivaldi Biosciences, Inc., please visit www.vivaldibiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.